Skip to content
Tyche Industries logo

Tyche Industries

532384 BSE
Price unavailable

Tyche Industries (TYCHE) share price was ₹102.00 at the 28 Oct 2026 close; market capitalisation ₹105 Cr; P/E (TTM) 23.50; sector Healthcare. The share price fell 23.7% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue fell 28.4% year on year to ₹9.1 Cr and net profit was −₹0.04 Cr, against ₹2.43 Cr a year earlier (compared with Jun 2025). Promoters held 61.97% of Tyche Industries in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 53/100 (Average) as of 28 Oct 2026.

Close 28 Oct 2026 ₹102.00 −31.60 −23.65% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹105 Cr
P/E (TTM)
23.5
EBITDA
₹11.50 Cr
Return on Equity
4.94%
Debt to Equity
0
Book Value
₹137.05
EPS (TTM)
₹4.34
52W High
₹148.00
52W Low
₹99.00

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Standalone · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,766.7035.054,23,891 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,655.0087.632,56,310 Cr15.290.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,610.5072.381,75,369 Cr9.540.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,188.00108.101,18,220 Cr22.310.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.3026.291,17,835 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,338.7034.671,11,739 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,364.8032.701,10,257 Cr3.120.96%11.21%14.88%28,589 Cr3,356 Cr
Tyche Industries (this company)
—23.50105 Cr0.743.43%4.94%6.69%60 Cr4 Cr
Median 8 companies₹1,766.7034.861,18,028 Cr4.710.72%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

53 Average
Overall score

Data confidence 98/100

Category scores

Quality Good 60
Returns, margins, earnings quality 22% weight
Valuation Good 59
Cheap vs sector & own history 24% weight
Growth Poor 14
Sales & profit trajectory 9% weight
Financial Health Strong 86
Solvency, leverage, coverage 9% weight
Momentum Poor 30
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

4
  • Company is almost debt free.
  • Stock is trading at 0.77 times its book value
  • Stock is providing a good dividend yield of 3.31%.
  • Company has been maintaining a healthy dividend payout of 32.5%

Weaknesses

4
  • The company has delivered a poor sales growth of -7.28% over past five years.
  • Company has a low return on equity of 8.05% over last 3 years.
  • Earnings include an other income of Rs.9.72 Cr.
  • Debtor days have increased from 110 to 133 days.

Technical Indicators

Oscillators

Neutral

Bearish
2
Neutral
5
Bullish
2

Overall

Bearish

Bearish
12
Neutral
5
Bullish
2

Moving Averages

Bearish

Bearish
10
Neutral
0
Bullish
0

Growth Rate

Revenue Growth
-13.72% lower than 3Y

change over 1 year

Net Income Growth
-44.35% lower than 3Y

change over 1 year

Cash Flow Change
-66.63%

change over 1 year

EBITDA Margin Change
-28.94%

change over 1 year Operating margin -18.57% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
17.05
16.04
22.22
14.2
15.52
20.54
17.75
12.37
12.7
14.16
10.58
16.2
9.1
Expenses
14.25
12.91
17.39
12.32
12.9
15.82
12.92
12.55
10.76
14.29
9.49
16.87
10.79
Operating Profit
2.8
3.13
4.83
1.88
2.62
4.72
4.83
-0.18
1.94
-0.13
1.09
-0.67
-1.69
OPM %
16.42%
19.51%
21.74%
13.24%
16.88%
22.98%
27.21%
-1.46%
15.28%
-0.92%
10.3%
-4.14%
-18.57%
Other Income
1.29
1.53
1.51
1.59
1.52
1.14
2.04
2.01
1.77
2.65
1.85
2.96
2.26
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0.46
0.47
0.48
0.54
0.49
0.49
0.5
0.5
0.45
0.47
0.48
0.59
0.62
PBT
3.63
4.19
5.86
2.93
3.65
5.37
6.37
1.33
3.26
2.05
2.46
1.7
-0.05
Tax %
25.07%
25.3%
26.79%
28.67%
24.93%
25.51%
25.75%
28.57%
25.46%
25.85%
26.02%
31.76%
-20%
Net Profit
2.71
3.14
4.29
2.1
2.73
3.99
4.74
0.94
2.43
1.52
1.82
1.15
-0.04
EPS (₹)
2.64
3.06
4.19
2.05
2.66
3.89
4.62
0.92
2.37
1.48
1.78
1.12
-0.04
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
63.86
54.08
42.61
51.6
53.95
73.7
78.24
62.27
75.39
69.51
65.47
53.63
50.04
Expenses
56.8
51.16
36.62
42.57
44.78
52.31
53.52
51.3
59.24
56.86
54.18
51.39
51.44
Operating Profit
7.06
2.92
5.99
9.03
9.17
21.39
24.72
10.97
16.15
12.65
11.29
2.24
-1.4
OPM %
11.06%
5.4%
14.06%
17.5%
17%
29.02%
31.6%
17.62%
21.42%
18.2%
17.24%
4.18%
-2.8%
Other Income
0.25
1.68
1.89
1.69
2.52
3.68
3.75
3.46
4.71
5.92
7.42
9.22
9.72
Interest
1.11
0.29
0.08
0.01
0
0
0.01
0
0
0
0
0
0
Depreciation
3.34
1.76
1.87
1.85
1.84
1.74
1.72
1.79
1.77
1.94
1.99
2
2.16
PBT
2.86
2.55
5.93
8.86
9.85
23.33
26.74
12.64
19.09
16.63
16.72
9.46
6.16
Tax %
32.87%
3.53%
48.06%
33.86%
27.41%
24.73%
25.24%
26.11%
25.72%
26.4%
25.72%
26.74%
—
Net Profit
1.93
2.47
3.08
5.86
7.15
17.56
19.98
9.33
14.17
12.24
12.41
6.94
4.45
EPS (₹)
1.88
2.41
3
5.72
6.98
17.13
19.49
9.1
13.82
11.94
12.11
6.77
4.34
Div. Payout %
26.5%
20.71%
16.61%
8.75%
7.17%
0%
5.13%
16.48%
0%
20.94%
24.78%
51.69%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
10.23
10.23
10.23
10.25
10.25
10.25
10.25
10.25
10.25
10.25
10.25
10.25
Reserves
33.56
35.36
37.66
42.88
50.02
66.93
85.72
93.97
107
116
126
130
Borrowings
8.68
10.83
0
0.07
0.04
0
0
0
0
0
0
0
Other Liabilities
11.51
11.01
13.1
13.52
13.7
17.52
20.98
16.05
19.95
7.95
10.69
7.56
Total Liabilities
63.98
67.43
60.99
66.72
74.01
94.7
117
120
137
135
147
148
Fixed Assets
28.98
28.4
26.57
19.84
19.15
17.67
17.93
16.63
16.61
17.9
16.48
18.88
CWIP
0.38
0.33
0.33
0
0
0
0.53
0
0
0
0.16
0
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
34.62
38.7
34.09
46.88
54.86
77.03
98.49
104
120
117
131
129
Total Assets
63.98
67.43
60.99
66.72
74.01
94.7
117
120
137
135
147
148
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
2.31
11.96
11.37
5.04
3.75
15.21
15.45
4.46
6.43
7.71
8.54
2.85
Investing
-0.98
-1.34
0.6
6.29
0.63
2.04
0.42
3.16
-3.12
3.94
-0.39
-8.95
Financing
-3.24
1.59
-10.59
-0.6
-0.07
-0.62
-1.02
-1.02
-1.54
-2.05
-2.56
-3.07
Net Cash Flow
-1.9
12.2
1.38
10.72
4.31
16.63
14.85
6.59
1.77
9.61
5.59
-9.17
Free Cash Flow
1.33
10.82
11.33
10.25
2.61
14.95
12.95
4.58
4.68
4.48
7.84
-1.39
CFO/OP
33
410
190
56
41
71
62
41
40
61
76
127
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
90.65
107
81.12
68.05
68.81
64.04
79.91
96.25
107
100
95.45
133
Inventory Days
138
67.76
83.68
85.37
123
122
148
148
195
157
245
150
Days Payable
75.69
92.82
131
86.81
95.79
91.41
93.04
77.86
134
47.91
85.26
37.78
Cash Conversion Cycle
153
81.65
34.3
66.61
95.87
94.34
135
167
168
210
255
245
Working Capital Days
77.39
21.46
60.48
66.63
86.53
77.11
82.76
121
129
144
150
177
ROCE %
7.37%
5.22%
11.52%
17.55%
17.36%
33.92%
32.04%
13.32%
17.39%
13.66%
12.68%
6.83%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Tyche Industries insights

63 extracted metrics + investor summaries across FY10–FY27.

Shareholding Pattern

Promot.61.97%Others10.97%Public27.06%As ofSep 2026

Documents

Frequently Asked Questions about Tyche Industries

What does Tyche Industries Ltd do?
Incorporated in 1998, Tyche Industries Ltd does manufacturing of active pharmaceutical ingredients[1]
Where is Tyche Industries Ltd (TYCHE) listed?
Tyche Industries Ltd trades under code 532384 on the BSE.
Which sector does Tyche Industries Ltd belong to?
Tyche Industries Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Tyche Industries Ltd?
Tyche Industries Ltd has a market capitalisation of ₹104.57 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Tyche Industries Ltd?
Tyche Industries Ltd trades at a PE ratio of 23.50 as of 28 Oct 2026, on earnings per share of ₹4.34, against a book value of ₹137.05 per share.
What is the 52-week high and low of Tyche Industries Ltd?
Over the last 52 weeks Tyche Industries Ltd has traded between ₹99 and ₹148 as of 28 Oct 2026.
Does Tyche Industries Ltd pay dividends?
Tyche Industries Ltd has a dividend yield of 3.43%.
What is the Return on Equity (ROE) of Tyche Industries Ltd?
Tyche Industries Ltd reported a return on equity of 4.94%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1998, Tyche Industries Ltd does manufacturing of active pharmaceutical ingredients[1]

Website tycheindustries.net
Listed 2000-11-28
Face Value ₹ 10
Shares Outstanding 1,02,51,938

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/532384.md for Tyche Industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month